<DOC>
	<DOCNO>NCT00152217</DOCNO>
	<brief_summary>This control study design evaluate efficacy TS-1 survival compare surgery alone . Patients randomly assign receive either surgery alone surgery follow treatment TS-1 within 45 day curative resection ( curability A B ) . To assess efficacy , data recurrence survival collect time enrollment 5 year surgery . To evaluate safety , data adverse event collect time enrollment 1 year surgery .</brief_summary>
	<brief_title>Adjuvant Chemotherapy Trial TS-1 Gastric Cancer ( ACTS-GC )</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Age 20 80 Hematopoietic WBC ≥ 4,000/mm^3 Platelet ≥ 100,000/mm^3 Hepatic AST ALT ≤ 2.5 time upper limit normal ( ULN ) Total bilirubin ≤ 1.5 mg/dL Renal Creatinine ≤ULN Prior anticancer treatment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Stomach cancer</keyword>
</DOC>